Edition:
United States

Bayer AG (BAYGn.DE)

BAYGn.DE on Xetra

94.54EUR
11:35am EST
Change (% chg)

€1.37 (+1.47%)
Prev Close
€93.17
Open
€93.95
Day's High
€94.73
Day's Low
€93.06
Volume
3,269,236
Avg. Vol
2,280,577
52-wk High
€119.05
52-wk Low
€83.45

Latest Key Developments (Source: Significant Developments)

Credit Suisse, Bank Of America lead financial advisors to Bayer in Monsanto deal
Wednesday, 14 Sep 2016 08:01am EDT 

: Credit Suisse acting with Bank Of America Merrill Lynch as lead financial advisors and structuring banks to Bayer in addition to providing committed financing for the Bayer/Monsanto deal (Reporting by Zurich Newsroom) ((zurich.newsroom@thomsonreuters.com; +41 58 306 7336;)).  Full Article

Bayer targeting annual cost synergies of $1.2 bln -slides
Wednesday, 14 Sep 2016 07:51am EDT 

Bayer : Says agrees to buy monsanto . Says pays last 12 month ebitda multiple of 18.6x as of may 31, 2016; consensus(3) fy 2017 ebitda multiple of 16.5x . Says deal accretive to core eps in the first full year after closing; double-digit percentage core eps accretion expected in the third full year after closing . Says targeting $1.2 billion in annual cost synergies, $0.3 billion in sales synergies after year 3 . Says dividend payout ratio of 30-40% of core eps to be maintained Further company coverage: [BAYGn.DE] (Frankfurt newsroom) ((+49 69 7565 1270; Reuters Messaging: frankfurt.newsroom@thomsonreuters.net)).  Full Article

Bayer to acquire Monsanto for an aggregate deal value of $66 bln
Wednesday, 14 Sep 2016 07:20am EDT 

Bayer AG : Bayer and Monsanto to create a global leader in agriculture . Aggregate deal value of $66 billion . Bayer shareholders expected to benefit from accretion to core EPS in first FY after closing, double-digit percent accretion in third FY . Bayer AG says combined agriculture business will have its global seeds & traits and North American commercial headquarters in St. Louis, Missouri .Says combined agriculture business will have its global crop protection and overall crop science headquarters in Monheim, Germany.  Full Article

Bayer proposes improved Monsanto offer of $129 a share - Bloomberg
Tuesday, 13 Sep 2016 02:36pm EDT 

:Bayer proposes improved Monsanto offer of $129 a share -Bloomberg.  Full Article

Bayer to explore sale of $1.1 bln dermatology business - Bloomberg
Thursday, 8 Sep 2016 01:06pm EDT 

: Bayer said to explore sale of $1.1 billion dermatology business - Bloomberg, citing source . Bayer is working with J.P. Morgan Chase & Co on the sale, which could fetch more than 1 billion euros ($1.1 billion)- Bloomberg, citing source . Business could attract interest from Nestle Sa's Galderma, Allergan Plc and Almirall Sa of Spain, as well as private equity firms - Bloomberg Further company coverage: [BAYGn.DE] ((Bangalore.newsroom@thomsonreuters.com;)).  Full Article

Bayer & Monsanto seen closing in on deal - CNBC, citing sources
Tuesday, 6 Sep 2016 09:00am EDT 

: Bayer & Monsanto seen closing in on deal; Monsanto told Bayer it is "close" on price- CNBC, citing sources . Bayer, Monsanto deal could happen within a week or two- CNBC, Citing Sources.  Full Article

Monsanto confirms updated proposal from Bayer
Monday, 5 Sep 2016 10:53pm EDT 

: Monsanto confirms updated proposal from Bayer . Monsanto Company - Confirmed it has been engaged in constructive negotiations with Bayer AG . Monsanto Company - Has received an updated non-binding proposal for a potential acquisition of Monsanto for $127.50 per share in cash. .Monsanto Company - Continuing conversations as it evaluates Bayer's proposal, as well as proposals from other parties and other strategic alternatives.  Full Article

Bayer says prepared to offer $127.50 per Monsanto share under an agreement
Monday, 5 Sep 2016 06:41pm EDT 

Bayer : Says confirms advanced negotiations with monsanto concerning a proposed transaction . Bayer says the key conditions of a definitive transaction agreement must be approved by the supervisory board of bayer ag. . Bayer says there can be no assurance that the parties will enter into an agreement .Bayer says while key terms and conditions have not yet been agreed, bayer would be prepared to provide a transaction consideration of usd 127.50 per monsanto share only in connection with a negotiated transaction..  Full Article

Bayer confirms advanced negotiations with Monsanto concerning a proposed transaction
Monday, 5 Sep 2016 06:38pm EDT 

Bayer Ag : Confirms advanced negotiations with Monsanto concerning a proposed transaction . There can be no assurance that the parties will enter into an agreement . Co would be prepared to provide transaction consideration of $127.50 per Monsanto share only in connection with a negotiated transaction .Key terms and conditions have not yet been agreed.  Full Article

Evotec achieves milestone in alliance with Bayer
Thursday, 4 Aug 2016 01:57am EDT 

Evotec Ag : news: evotec achieves clinical development milestone as part of its multi-target alliance with bayer in endometriosis . Says has reached a milestone from bayer for progression of a programme from alliance portfolio into phase i clinical development for treatment of endometriosis, triggering a milestone payment to evotec .Says milestone was achieved under strategic alliance between evotec and bayer entered in october 2012.  Full Article

Photo

French add to U.S. concerns about Bayer contraceptive implant

PARIS Women in France who have used Bayer's contraceptive implant Essure have launched a legal complaint about side-effects similar to a challenge already underway in the United States.